Beacon Capital Management LLC (Tennessee)’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4K | Hold |
|
|||||
|
2025
Q1 | $29.2K | Hold |
|
|||||
|
2024
Q4 | $30.8K | Hold |
|
|||||
|
2024
Q3 | $65.7K | Hold |
|
|||||
|
2024
Q2 | $54K | Hold |
|
|||||
|
2024
Q1 | $57.1K | Hold |
|
|||||
|
2023
Q4 | $45.9K | Buy |
|
|||||
|
2023
Q3 | $18.2K | Hold |
|
|||||
|
2023
Q2 | $18.2K | Hold |
|
|||||
|
2023
Q1 | $26.5K | Hold |
|
|||||
|
2022
Q4 | $14.2K | Buy |
|